Universitätsklinikum Essen

Effectiveness of Dabrafenib plus Trametinib during the Treatment of Melanoma Patients with BRAFV600 mutated Brain Metastases (2020) Berking C, Schadendorf D, Weichenthal M, Eigentler T, Schober K, Mohr P, Kiecker F, et al. Conference contribution Agranulocytosis with Immune Checkpoint-Blockade - a retrospective, multicenter Evaluation (2020) Zaremba A, Martaki A, Salzmann M, Baroudjian B, Sachse MM, Gesierich A, Reinhardt L, et al. Conference contribution Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts (2020) Garbe C, Keim U, Suciu S, Amaral T, Eigentler TK, Gesierich A, Hauschild A, et al. Journal article Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? (2020) Bodei L, Bergsland E, de Herder WW, Ferone D, Hicks RJ, Hope TA, Kunikowska J, et al. Journal article Associations Between Acculturation, Depressive Symptoms, and Life Satisfaction Among Migrants of Turkish Origin in Germany: Gender- and Generation-Related Aspects (2020) Morawa E, Brand T, Dragano N, Jockel KH, Moebus S, Erim Y Journal article Risk factors for mixed chimerism in children with hemophagocytic lymphohistiocytosis after reduced toxicity conditioning (2020) Wustrau K, Greil J, Sykora KW, Albert MH, Burkhardt B, Lang P, Meisel R, et al. Journal article RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial (2020) Martin D, Balermpas P, Gollrad J, Weiss C, Valentini C, Stuschke M, Schaefer H, et al. Journal article Artificial Intelligence in Skin Cancer Diagnostics: The Patients' Perspective (2020) Jutzi TB, Krieghoff-Henning EI, Holland-Letz T, Utikal JS, Hauschild A, Schadendorf D, Sondermann W, et al. Journal article DOES ANTI-ACID TREATMENT INFLUENCE DISEASE PROGRESSION IN SYSTEMIC SCLEROSIS INTERSTITIAL LUNG DISEASE (SSC-ILD)? DATA FROM THE GERMAN SSC-NETWORK (2020) Kreuter M, Bonella F, Riemekasten G, Mueller-Ladner U, Henes J, Siegert E, Guenther C, et al. Conference contribution Nebenwirkungsmanagement bei Immun-Checkpoint-Blockade durch CTLA-4- und PD-1-Antikörper beim metastasierten Melanom – ein Update (2020) Kähler KC, Hassel JC, Heinzerling L, Loquai C, Thoms KM, Ugurel S, Zimmer L, Gutzmer R Journal article